Dexorgen Inc.
Dba Codex Biosolutions Inc
Div Research And Development
CAGE Code: 62JZ3
NCAGE Code: 62JZ3
Status: Active
Type: Commercial Supplier
Dun & Bradstreet (DUNS): 963268094
Summary
Dexorgen Inc., Dba Codex Biosolutions Inc, Div Research And Development is an Active Commercial Supplier with the Cage Code 62JZ3 and is tracked by Dun & Bradstreet under DUNS Number 963268094..
Address
12358 Parklawn Dr
Ste 250A
Rockville MD 20852-2175
United States
Points of Contact
Related Information
People who viewed this 'CAGE Code' also viewed...
Dansources Technical Services, Inc. Linda Fang Ht Medical Systems Inc Stream Intl Inc Air Services Inc Lcg Inc Social And Health Services Ltd S.S. Papadopulos & Associates, Inc. Twinbrook Tv And Computer Covington Sharon N Dictaphone Corp Sgl Industries Inc Selecter Div Polytronic Research Inc White Flint Pharmacy Inc Copy Supply Llc Wardwell Richard E Inc Tec Inc Sporicidin International Computer Pros Inc Dally James
Frequently Asked Questions (FAQ) for CAGE 62JZ3
- What is CAGE Code 62JZ3?
- 62JZ3 is the unique identifier used by NATO Organizations to reference the physical entity known as Dexorgen Inc. Dba Codex Biosolutions Inc Div Research And Development located at 12358 Parklawn Dr, Ste 250A, Rockville MD 20852-2175, United States.
- Who is CAGE Code 62JZ3?
- 62JZ3 refers to Dexorgen Inc. Dba Codex Biosolutions Inc Div Research And Development located at 12358 Parklawn Dr, Ste 250A, Rockville MD 20852-2175, United States.
- Where is CAGE Code 62JZ3 Located?
- CAGE Code 62JZ3 is located in Rockville, MD, USA.
Contracting History for CAGE 62JZ3 Most Recent 25 Records
- 75N95023P00373
- Custom P/Q Type Calcium Channel Cav2.1 Cell Lines
- 26 Jun 2023
- Custom P/Q Type Calcium Channel Cav2.1 Cell Lines
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $35,025.00
- Department Of Health And Human Services (Hhs)
- 75N95023P00373
- Custom P/Q Type Calcium Channel Cav2.1 Cell Lines
- 15 Aug 2023
- Custom P/Q Type Calcium Channel Cav2.1 Cell Lines
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $35,025.00
- Department Of Health And Human Services (Hhs)
- 75N95C22P00113
- Construct 293T Stable Cell Lines That Stably Express Sars2 Spike Ba.4 And Ba.5 Variants And Mcherry Fluorescence Protein (Covid-19)
- 9 Sep 2022
- Construct 293T Stable Cell Lines That Stably Express Sars2 Spike Ba.4 And Ba.5 Variants And Mcherry Fluorescence Protein (Covid-19)
- National Institutes Of Health Ncats
- Department Of Health And Human Services (Hhs)
- $14,700.00
- Department Of Health And Human Services (Hhs)
- 75N94019C00010
- Eo14042 Development Of Novel Pde4b Inhibitors To Treat Alcohol Use Disorder Sbir Phase Ii
- 8 May 2023
- Eo14042 Development Of Novel Pde4b Inhibitors To Treat Alcohol Use Disorder Sbir Phase Ii
- National Institutes Of Health Nichd
- Department Of Health And Human Services (Hhs)
- $998,800.00
- Department Of Health And Human Services (Hhs)
- 75N94019C00010
- Development Of Novel Pde4b Inhibitors To Treat Alcohol Use Disorder (Sbir Phase Ii)
- 17 Aug 2021
- Development Of Novel Pde4b Inhibitors To Treat Alcohol Use Disorder (Sbir Phase Ii)
- National Institutes Of Health Nichd
- Department Of Health And Human Services (Hhs)
- $998,800.00
- Department Of Health And Human Services (Hhs)
- 75N94019C00010
- Eo14042 Development Of Novel Pde4b Inhibitors To Treat Alcohol Use Disorder Sbir Phase Ii
- 22 Dec 2023
- Eo14042 Development Of Novel Pde4b Inhibitors To Treat Alcohol Use Disorder Sbir Phase Ii
- National Institutes Of Health Nichd
- Department Of Health And Human Services (Hhs)
- $998,800.00
- Department Of Health And Human Services (Hhs)
- 75N94019C00010
- Eo14042 Development Of Novel Pde4b Inhibitors To Treat Alcohol Use Disorder Sbir Phase Ii
- 19 Sep 2023
- Eo14042 Development Of Novel Pde4b Inhibitors To Treat Alcohol Use Disorder Sbir Phase Ii
- National Institutes Of Health Nichd
- Department Of Health And Human Services (Hhs)
- $998,800.00
- Department Of Health And Human Services (Hhs)
- 75N94019C00010
- Development Of Novel Pde4b Inhibitors To Treat Alcohol Use Disorder (Sbir Phase Ii)
- 20 Sep 2019
- Development Of Novel Pde4b Inhibitors To Treat Alcohol Use Disorder (Sbir Phase Ii)
- National Institutes Of Health Nichd
- Department Of Health And Human Services (Hhs)
- $998,800.00
- Department Of Health And Human Services (Hhs)
- 75N93018C00016
- The Purpose Of This Contract Is To Identify Several Cellular Factors That Have A Major Impact On Production Of A Full-Length Hiv-1 Envelope Trimer Without Altering Its Native Antigenic Properties.
- 8 Jan 2021
- The Purpose Of This Contract Is To Identify Several Cellular Factors That Have A Major Impact On Production Of A Full-Length Hiv-1 Envelope Trimer Without Altering Its Native Antigenic Properties.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $599,424.00
- Department Of Health And Human Services (Hhs)
- HHSN275201700001C
- Development Of Novel Pde4b Inhibitors To Treat Alcohol Use Disorder(Sbir Phase I)
- 5 Jun 2018
- Development Of Novel Pde4b Inhibitors To Treat Alcohol Use Disorder(Sbir Phase I)
- National Institutes Of Health Nichd
- Department Of Health And Human Services (Hhs)
- $224,656.00
- Department Of Health And Human Services (Hhs)
- 75N95020P00200
- Codex Biosolutions:1203128 [20-004084]
- 5 May 2020
- Codex Biosolutions:1203128 [20-004084]
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $13,230.00
- Department Of Health And Human Services (Hhs)
- 75N95019P00387
- Codex Biosolutions:1203128 [19-003128]
- 24 Jun 2019
- Codex Biosolutions:1203128 [19-003128]
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $18,000.00
- Department Of Health And Human Services (Hhs)
- 75N93023P01252
- Expi293 Stable Cell Line Overexpressing Htlv Envelope Protein (Ambis #2183770)
- 13 Sep 2023
- Expi293 Stable Cell Line Overexpressing Htlv Envelope Protein (Ambis #2183770)
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $22,620.00
- Department Of Health And Human Services (Hhs)
- 75N93021P01316
- Cell Line Construction For Gpcr Receptor Screening
- 3 Sep 2021
- Cell Line Construction For Gpcr Receptor Screening
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $24,840.00
- Department Of Health And Human Services (Hhs)
- 75N95018P00666
- Igf-Ot-Igf Cell-Line Receptor Expression
- 13 Sep 2018
- Igf-Ot-Igf Cell-Line Receptor Expression
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $11,250.00
- Department Of Health And Human Services (Hhs)
- 75N93021P00929
- Codex Biosolutions, Inc (Ambis #2077634): Cell Line Construction
- 7 Jul 2021
- Codex Biosolutions, Inc (Ambis #2077634): Cell Line Construction
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $16,000.00
- Department Of Health And Human Services (Hhs)
- 75N95C22P00083
- Pseudoparticles For Sars-Cov-2 Entry Inhibition Assay
- 13 Jul 2022
- Pseudoparticles For Sars-Cov-2 Entry Inhibition Assay
- National Institutes Of Health Ncats
- Department Of Health And Human Services (Hhs)
- $14,625.00
- Department Of Health And Human Services (Hhs)
- 75N93018C00016
- The Purpose Of This Contract Is To Identify Several Cellular Factors That Have A Major Impact On Production Of A Full-Length Hiv-1 Envelope Trimer Without Altering Its Native Antigenic Properties.
- 13 Dec 2019
- The Purpose Of This Contract Is To Identify Several Cellular Factors That Have A Major Impact On Production Of A Full-Length Hiv-1 Envelope Trimer Without Altering Its Native Antigenic Properties.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $599,424.00
- Department Of Health And Human Services (Hhs)
- 75N95C23P00025
- Pseudoparticles Of Sars-Cov-2 Strains
- 24 Jan 2023
- Pseudoparticles Of Sars-Cov-2 Strains
- National Institutes Of Health Ncats
- Department Of Health And Human Services (Hhs)
- $15,375.00
- Department Of Health And Human Services (Hhs)
- 75N95023P00701
- Codex Biosolutions:1203128 [23-006664]
- 1 Sep 2023
- Codex Biosolutions:1203128 [23-006664]
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $24,950.00
- Department Of Health And Human Services (Hhs)
- 75N93018C00016
- The Purpose Of This Contract Is To Identify Several Cellular Factors That Have A Major Impact On Production Of A Full-Length Hiv-1 Envelope Trimer Without Altering Its Native Antigenic Properties.
- 26 Jul 2018
- The Purpose Of This Contract Is To Identify Several Cellular Factors That Have A Major Impact On Production Of A Full-Length Hiv-1 Envelope Trimer Without Altering Its Native Antigenic Properties.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $599,424.00
- Department Of Health And Human Services (Hhs)
- 75N95021P00527
- Pmlv-Sars-Cov-2-Luciferase Pseudovirus Particle
- 10 Sep 2021
- Pmlv-Sars-Cov-2-Luciferase Pseudovirus Particle
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $24,360.00
- Department Of Health And Human Services (Hhs)
- 75N95024P00026
- Codex Biosolutions:1203128 [24-000295]
- 21 Nov 2023
- Codex Biosolutions:1203128 [24-000295]
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $29,400.00
- Department Of Health And Human Services (Hhs)
- 75N93018C00016
- The Purpose Of This Contract Is To Identify Several Cellular Factors That Have A Major Impact On Production Of A Full-Length Hiv-1 Envelope Trimer Without Altering Its Native Antigenic Properties.
- 6 Jul 2020
- The Purpose Of This Contract Is To Identify Several Cellular Factors That Have A Major Impact On Production Of A Full-Length Hiv-1 Envelope Trimer Without Altering Its Native Antigenic Properties.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $599,424.00
- Department Of Health And Human Services (Hhs)
- 75N95023P00700
- Cell Line Generation Service
- 1 Sep 2023
- Cell Line Generation Service
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $18,400.00
- Department Of Health And Human Services (Hhs)